FDA Announced diazepam shortage

July 19, 2022

The FDA announced that there is an ongoing shortage of both brand and generic forms of diazepam rectal gel. This medication is used for rescue therapy in people with epilepsy, including children. The Epilepsy Foundation strongly encourages you to speak with your healthcare provider about your/your child’s options for rescue therapy, since new FDA-approved rescue therapy products have entered the market.

Learn more about rescue therapies at https://www.epilepsy.com/treatment/seizure-rescue-therapies

Related Posts

Medication Recall Alert Sabril® (Vigabatrin)

Medication Recall Alert Sabril® (Vigabatrin)

Our friends at the Epielpsy Foundation have shared the Following Medication Recall The company that makes Sabril® (vigabatrin) for oral solution, a prescription medication to manage seizures in children and adults, has announced a recall of this medication because of...

MEDICATION ALERT – FELBAMATE (Generic)

MEDICATION ALERT – FELBAMATE (Generic)

We understand that some families in our community may be having challenges getting prescriptions filled for generic Felbamate oral suspension and tablets. If you need assistance with obtaining your medication, contact our 24/7 Helpline at 1-800-332-1000 for connection...

Medicaid Eligibility Renewals are Coming!

Medicaid Eligibility Renewals are Coming!

Medicaid Eligibility Renewals are Coming! Medicaid eligibility renewals were paused during the COVID-19 pandemic but are re-starting soon. This means that almost everyone on Medicaid in the US will need to renew their eligibility at some point between February 2023...